These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9499991)

  • 21. Hepatitis C virus core protein: an update on its molecular biology, cellular functions and clinical implications.
    Irshad M; Dhar I
    Med Princ Pract; 2006; 15(6):405-16. PubMed ID: 17047346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical presentation of GB-C virus infection in drug abusers with chronic hepatitis C.
    Goeser T; Seipp S; Wahl R; Müller HM; Stremmel W; Theilmann L
    J Hepatol; 1997 Mar; 26(3):498-502. PubMed ID: 9075655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consensus guidelines for the management of hepatitis C infection.
    Consensus Guidelines Committee for the Management of Hepatitis C Infection
    Saudi Med J; 2003 Jul; 24 Suppl 2():S99-118. PubMed ID: 25121186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative analysis of hepatitis C virus activity in vivo in different groups of untreated patients.
    Manzin A; Solforosi L; Giostra F; Bianchi FB; Bruno S; Rossi S; Gabrielli A; Candela M; Petrelli E; Clementi M
    Arch Virol; 1997; 142(3):465-72. PubMed ID: 9349293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiology of hepatitis C virus infection.
    Camps J; Córdoba J; Esteban JI
    Pathol Biol (Paris); 1995 Oct; 43(8):691-702. PubMed ID: 8745591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospects for hepatitis C vaccine.
    Zuckerman AJ; Zuckerman JN
    J Hepatol; 1995; 22(1 Suppl):97-100. PubMed ID: 7602087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic heterogeneity of hepatitis C virus. The clinical significance of genotypes and quasispecies behavior.
    Marrone A; Sallie R
    Clin Lab Med; 1996 Jun; 16(2):429-49. PubMed ID: 8792081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular virology of hepatitis C].
    Moradpour D; Brass V; Gosert R; Wölk B; Blum HE
    Praxis (Bern 1994); 2002 Dec; 91(51-52):2247-53. PubMed ID: 12564041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.
    Gottwein JM; Scheel TK; Jensen TB; Lademann JB; Prentoe JC; Knudsen ML; Hoegh AM; Bukh J
    Hepatology; 2009 Feb; 49(2):364-77. PubMed ID: 19148942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatitis C virus. Virological diagnosis].
    Lunel F; Pawlotsky JM
    Pathol Biol (Paris); 1995 Oct; 43(8):681-90. PubMed ID: 8745590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus infection: diagnosis, natural course and therapy.
    Tillmann HL; Manns MP
    Kidney Blood Press Res; 1996; 19(3-4):215-9. PubMed ID: 8887264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replicative level of hepatitis C virus (HCV) in chronic hepatitis C.
    Hayashi N; Kamada T
    Intern Med; 1993 Dec; 32(12):944-5. PubMed ID: 8204979
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatitis C virus.
    IARC Monogr Eval Carcinog Risks Hum; 1994; 59():165-221. PubMed ID: 7933462
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prediction of the outcome of IFN therapy in type C chronic hepatitis from serological grouping of hepatitis C virus].
    Sakai A; Yanagi M; Unoura M; Kobayashi K
    Nihon Rinsho; 1994 Jul; 52(7):1759-62. PubMed ID: 7521415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of hepatitis C viremia in patients receiving hemodialysis.
    Umlauft F; Gruenewald K; Weiss G; Kessler H; Urbanek M; Haun M; Santner B; Koenig P; Keeffe EB
    Am J Gastroenterol; 1997 Jan; 92(1):73-8. PubMed ID: 8995941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The hepatitis C virus core protein indirectly induces alpha-smooth muscle actin expression in hepatic stellate cells via interleukin-8.
    Clément S; Pascarella S; Conzelmann S; Gonelle-Gispert C; Guilloux K; Negro F
    J Hepatol; 2010 May; 52(5):635-43. PubMed ID: 20347177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
    Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR
    J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan.
    Yu ML; Chuang WL; Chen SC; Dai CY; Hou C; Wang JH; Lu SN; Huang JF; Lin ZY; Hsieh MY; Tsai JF; Wang LY; Chang WY
    J Med Virol; 2001 Sep; 65(1):58-65. PubMed ID: 11505444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perinatal transmission of hepatitis G virus (GB virus type C) and hepatitis C virus infections--a comparison.
    Wejstål R; Månson AS; Widell A; Norkrans G
    Clin Infect Dis; 1999 Apr; 28(4):816-21. PubMed ID: 10825044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end.
    Han JH; Shyamala V; Richman KH; Brauer MJ; Irvine B; Urdea MS; Tekamp-Olson P; Kuo G; Choo QL; Houghton M
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1711-5. PubMed ID: 1705704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.